covid Vaccine

Finally, some good news related to a COVID-19 vaccine that we've all been waiting for. Not just any vaccine, but a vaccine that many experts believe will be the first in the world to be commercialised.

The UK government has announced that human trial of a potential Coronavirus vaccine being developed by Oxford University researchers will begin from Thursday. Last week, even the Indian Council of Medical Research (ICMR) has supported the Oxford vaccine, called 'ChAdOX1', calling it the frontrunner in the race for a COVID-19 vaccine.

According to the UK government, the potential Oxford University coronavirus vaccine will be on up to 510 people aged between 18 and 55, out of an overall group of 1,112 volunteers who've been selected and finalised for the COVID-19 vaccine trial.

The information of fast-tracking the Oxford vaccine trial was revealed by UK Health Secretary Matt Hancock while briefing the UK parliament on how they're pretty much 'throwing everything at' Britain's attempt to develop the first coronavirus vaccine in the world, according to a DailyMail report. 

That's not all, the UK government is also funding scientists with an extra 20 million pounds to help with their trials, and offering a further 22.5 million pounds to another Coronavirus vaccine project underway at the Imperial College London, according to an IANS report.